tezosentan and Acute Disease

Topics: Acute Disease; Atrial Natriuretic Factor; Benzoates; Elapid Venoms; Endothelin-1; Heart Failure; Humans; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nitrates; Peptide Fragments; Prognosis; Pyridines; Receptors, Endothelin; Relaxin; Tetrazoles; Vasoconstriction; Vasodilator Agents

Topics: Acute Disease; Drug Approval; Dyspnea; Forecasting; Heart Failure; Hospitalization; Humans; Hydrazones; Natriuretic Agents; Natriuretic Peptide, Brain; Pyridazines; Pyridines; Randomized Controlled Trials as Topic; Severity of Illness Index; Simendan; Tetrazoles; Treatment Outcome; Vasodilator Agents

Topics: Acute Disease; Cardiotonic Agents; Cohort Studies; Heart Failure; Hemodynamics; Humans; Hydrazones; Multicenter Studies as Topic; Natriuretic Agents; Natriuretic Peptide, Brain; Placebos; Pyridazines; Pyridines; Randomized Controlled Trials as Topic; Receptors, Endothelin; Simendan; Tetrazoles; Time Factors; Vasodilator Agents

Topics: Acute Disease; Animals; Clinical Trials as Topic; Heart Failure; Humans; Pyridines; Tetrazoles

Topics: Acute Disease; Analgesics, Opioid; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Critical Illness; Developed Countries; Diuretics; Emergency Service, Hospital; Emergency Treatment; Evidence-Based Medicine; Furosemide; Heart Failure; Humans; Hydrazones; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroprusside; Oxygen Inhalation Therapy; Patient Selection; Pulmonary Edema; Pyridazines; Pyridines; Simendan; Tetrazoles; Treatment Outcome; Vasodilator Agents

Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiotonic Agents; Clinical Trials as Topic; Endothelin Receptor Antagonists; Heart Failure; Humans; Hydrazones; Pyridazines; Pyridines; Simendan; Syndrome; Tetrazoles; Tolvaptan; Vasodilator Agents

Topics: Acute Disease; Aged; Blood Pressure; Cause of Death; Europe; Female; Heart Failure; Hospitalization; Humans; Male; Ontario; Pyridines; Survival Rate; Systole; Tetrazoles; Treatment Outcome; United States; Vasodilator Agents

Topics: Acute Disease; Aged; Disease Progression; Double-Blind Method; Female; Heart Failure; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Outcome Assessment, Health Care; Patient Admission; Pyridines; Tetrazoles; Vasodilator Agents

Topics: Acute Disease; Aged; Analysis of Variance; Double-Blind Method; Female; Heart Failure; Hospital Mortality; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Multivariate Analysis; Patient Discharge; Patient Readmission; Prognosis; Proportional Hazards Models; Pyridines; Survival Analysis; Tetrazoles; Time Factors; Treatment Outcome

Topics: Acute Disease; Aged; Biomarkers; Dose-Response Relationship, Drug; Europe; Female; Follow-Up Studies; Heart Failure; Hospital Mortality; Humans; Injections, Intravenous; Male; Middle Aged; Natriuretic Peptide, Brain; Patient Admission; Patient Discharge; Prognosis; Pyridines; Receptors, Endothelin; Retrospective Studies; Survival Rate; Tetrazoles; Time Factors; Troponin I; United States; Vasodilator Agents

Topics: Acute Disease; Adult; Child; Coronary Disease; Double-Blind Method; Endothelins; Female; Heart Failure; Humans; Myocardial Infarction; Pyridines; Recurrence; Syndrome; Tetrazoles; Vasodilator Agents

Topics: Acute Disease; Aged; Coronary Disease; Double-Blind Method; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Outcome Assessment, Health Care; Pilot Projects; Pyridines; Syndrome; Tetrazoles; Vasodilator Agents

Topics: Acute Disease; Aged; Coronary Disease; Endothelin Receptor Antagonists; Female; Heart Failure; Humans; Male; Multicenter Studies as Topic; Pyridines; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Tetrazoles; Troponin I; Vasodilator Agents

Topics: Acute Disease; Aged; Cardiac Output; Double-Blind Method; Dyspnea; Endothelin Receptor Antagonists; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Pulmonary Wedge Pressure; Pyridines; Tetrazoles; Treatment Outcome; Vascular Resistance; Vasodilator Agents

Topics: Acute Disease; Aged; Dobutamine; Double-Blind Method; Drug Tolerance; Echocardiography, Doppler; Endothelin Receptor Antagonists; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Pyridines; Safety; Tetrazoles

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acute Disease; Animals; Animals, Newborn; Chronic Disease; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Hypertension, Pulmonary; Injections, Intra-Arterial; Pulmonary Circulation; Pyridines; Random Allocation; Sheep; Tetrazoles; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents

Topics: Acute Disease; Adult; Double-Blind Method; Endothelin Receptor Antagonists; Female; Heart Failure; Humans; Male; Prospective Studies; Pyridines; Randomized Controlled Trials as Topic; Research Design; Tetrazoles; Vasodilator Agents

Topics: Acute Disease; Animals; Disease Models, Animal; Endothelin Receptor Antagonists; Hypoxia; Imaging, Three-Dimensional; Lung; Microspheres; Pulmonary Embolism; Pulmonary Gas Exchange; Pulmonary Ventilation; Pyridines; Receptors, Endothelin; Regional Blood Flow; Swine; Tetrazoles; Vasodilator Agents; Ventilation-Perfusion Ratio

Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Animals; Biomarkers; Coronary Angiography; Coronary Circulation; Coronary Thrombosis; Coronary Vasospasm; Coronary Vessels; Electrocardiography; Endothelin Receptor Antagonists; Endothelins; Female; Humans; Male; Microcirculation; Middle Aged; Prognosis; Prospective Studies; Pyridines; Research Design; Swine; Tetrazoles; Thrombectomy; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents

Topics: Acute Disease; Antihypertensive Agents; Bosentan; Chronic Disease; Clinical Trials as Topic; Endothelin Receptor Antagonists; Endothelin-1; Exercise Tolerance; Heart Failure; Hemodynamics; Humans; Phenylpropionates; Pyridines; Pyrimidines; Sulfonamides; Tetrazoles; Treatment Outcome; Vasodilator Agents